Statins and their utilization continues to be controversial. Increasing evidence is being presented that their therapeutic value may be open to question.
The two articles provided stimulate independent thought with regard to their status. What is clear is that they provide monumental income to the manufacturers and that physicians have been conditioned to prescribe them, something that clearly requires further discussion and evaluation. The articles speak for themselves.